Day One Biopharmaceuticals Inc (NASDAQ:DAWN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Scott Garland Other companies: Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Jan 7, 2026); LB Pharmaceuticals Inc (Chairman of the Board, LB Pharmaceuticals · Since at least Sep 10, 2025); Olema Pharmaceuticals, Inc. (Director · Since at least Oct 16, 2023); ALX Oncology Holdings Inc. (Chairman · Since at least Nov 28, 2022); Calithera Biosciences, Inc. (Director · Jul 10, 2020 – Jun 1, 2022 · Past); Portola Pharmaceuticals Inc (President and CEO, Director · Oct 8, 2018 – Jul 2, 2020 · Past); Karyopharm Therapeutics Inc. (Director · Nov 3, 2014 – Jun 6, 2019 · Past); Relypsa Inc (SVP & Chief Commercial Officer · Oct 31, 2014 – Sep 1, 2016 · Past); Exelixis, Inc. (EVP & Chief Commerical Officer · Oct 20, 2011 – Sep 18, 2013 · Past) | Director · Since at least Aug 16, 2021 |
| Habib Joseph Dable Other companies: Tyra Biosciences, Inc. (Director · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); PepGen Inc. (Director · Since at least Sep 20, 2022); Blueprint Medicines Corp (Director · Since at least Jun 23, 2022); Jade Biosciences, Inc. (Director · Jul 10, 2023 – Jun 5, 2024 · Past); Albireo Pharma Inc (Director · Aug 8, 2022 – Mar 2, 2023 · Past); Acceleron Pharma Inc (CEO and President, Director · Jan 4, 2021 – Nov 19, 2021 · Past) | Director · Since at least Jan 17, 2024 |
| Natalie Holles Other companies: LeonaBio, Inc. (Board Member | Chief Executive Officer · Since at least May 5, 2026); Aura Biosciences, Inc. (Chief Executive Officer and President and member of the Board · Since at least Apr 30, 2026); Third Harmonic Bio Inc. (CEO, Director · Since at least Sep 14, 2022); Allakos Inc (Director · Dec 21, 2020 – May 25, 2021 · Past); Rubius Therapeutics Inc (Director · Mar 19, 2019 – May 12, 2022 · Past); Audentes Therapeutics Inc (President and COO · Jul 19, 2016 – Jan 15, 2020 · Past); Hyperion Therapeutics Inc (SVP, Business Development · Jun 24, 2013 – May 7, 2015 · Past) | Director · Since at least May 26, 2021 |
| Saira Ramasastry Other companies: Sensei Biotherapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jun 15, 2026); Mirum Pharmaceuticals, Inc. (Director · Since at least Jun 2, 2022); Vir Biotechnology, Inc. (Director · Since at least Oct 10, 2019); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Repros Therapeutics (Director · Mar 25, 2013 – Jan 29, 2018 · Past); Filana Therapeutics, Inc. (Director · Feb 11, 2013 – Dec 13, 2019 · Past); Sangamo Therapeutics, Inc. (Director · Jun 21, 2012 – Feb 25, 2022 · Past) | Director · Since at least May 26, 2021 |
| Garry A Nicholson Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); NextCure, Inc. (Director · Jun 24, 2021 – Jun 22, 2023 · Past); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Turning Point Therapeutics Inc (Director · Jun 2, 2021 – Aug 17, 2022 · Past); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past) | Director · Since at least Sep 12, 2022 |
| Dan Becker Other companies: Zura Bio Limited (Director · Since at least May 21, 2025); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Pandion Therapeutics Inc (Director · Jul 16, 2020 – Apr 1, 2021 · Past); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 28, 2020 · Past) | Director · May 26, 2021 – Jun 22, 2023 · Past |
| Jeremy Bender Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Aura Biosciences, Inc. (Director · Since at least Jul 7, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Jan 1, 2024); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past) | CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021 |
| Michael Vasconcelles Other companies: Kura Oncology, Inc. (Director · Since at least Sep 13, 2024); ImmunoGen Inc (EVP R&D & MEDICAL AFFAIRS · Dec 29, 2022 – Feb 12, 2024 · Past); Dianthus Therapeutics, Inc. (Director · Aug 15, 2022 – Aug 15, 2022 · Past); Cogent Biosciences, Inc. (Chief Medical Officer · Mar 28, 2018 – Mar 1, 2019 · Past) | Head of Research and Dev. · Since at least Jun 16, 2025 |
| Lauren Merendino Other companies: ESSA Pharma Inc (Director · Jun 6, 2023 – Mar 25, 2024 · Past); Myovant Sciences Ltd (Chief Commercial Officer · Apr 5, 2021 – Mar 10, 2023 · Past) | Chief Commercial Officer · Since at least Feb 26, 2025 |
| William Grossman Other companies: enGene Therapeutics Inc. (Director · Since at least Jul 8, 2025); Arcus Biosciences, Inc. (Chief Medical Officer · Apr 29, 2019 – Jun 16, 2021 · Past) | Director · Since at least Jan 17, 2024 |
| Adam Dubow Other companies: Bristol-Myers Squibb Company (SVP,ChiefCompliance&EthicsOff. · Dec 5, 2019 – Jul 30, 2021 · Past) | Gen Counsel & Secretary · Since at least Nov 6, 2023 |
| Charles N York II Other companies: Spyre Therapeutics, Inc. (Chief Financial Officer and VP · Apr 6, 2016 – Feb 14, 2020 · Past) | COO and CFO · Since at least May 26, 2021 |
| Michael Gladstone Other companies: Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022) | Director · May 26, 2021 – May 23, 2024 · Past |
| John A Josey | Director · Since at least May 26, 2021 |
| Samuel C Blackman | HEAD OF R&D · May 26, 2021 – Dec 10, 2024 · Past |